Mankind Pharma Ltd Nine Monthly Results

Gross Sales

9,199.93

7,893.67

6,696.77

6,055.79

Excise Duty

0

0

0

0

Net Sales

9,199.93

7,893.67

6,696.77

6,055.79

Other Operating Income

0

0

0

0

Other Income

297.27

201.53

90.71

171.87

Total Income

9,497.2

8,095.2

6,787.48

6,227.67

Total Expenditure

6,838.33

5,949.71

5,212.81

4,351.27

PBIDT

2,658.87

2,145.49

1,574.67

1,876.39

Interest

238.94

24.15

39.31

45.58

PBDT

2,419.93

2,121.34

1,535.35

1,830.81

Depreciation

405.66

293.56

241.4

119.26

Minority Interest Before NP

0

0

0

0

Tax

464.59

378.06

238.44

454.68

Deferred Tax

-36.79

-15.46

39.54

-3.37

Reported Profit After Tax

1,586.47

1,465.18

1,015.98

1,260.24

Minority Interest After NP

16.28

23.52

19.56

16.85

Net Profit after Minority Interest

1,570.19

1,441.66

996.42

1,243.4

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

1,570.19

1,441.66

996.42

1,243.4

EPS (Unit Curr.)

39.14

35.99

24.87

31.04

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

40.06

40.06

40.06

40.06

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

28.9

27.17

23.51

30.98

PBDTM(%)

26.3

26.87

22.92

30.23

PATM(%)

17.24

18.56

15.17

20.81